Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jawahar Mehta to Blood Pressure

This is a "connection" page, showing publications Jawahar Mehta has written about Blood Pressure.

 
Connection Strength
  
 
 
2.236
  
  1. Deshmukh A, Pant S, Kumar G, Murugiah K, Mehta J. Seasonal variation in hypertensive emergency hospitalization. J Clin Hypertens (Greenwich). 2012 Apr; 14(4):269-70.
    View in: PubMed
    Score: 0.336
  2. Sinha AK, Mehta JL. Modulation of atherosclerosis, blood pressure and arterial elasticity by statins. Adv Cardiol. 2007; 44:315-330.
    View in: PubMed
    Score: 0.235
  3. Sarkar K, Sinha AK, Mehta JL. The role of statins in endothelial dysfunction in hypertension. Curr Opin Cardiol. 2006 Jul; 21(4):316-21.
    View in: PubMed
    Score: 0.226
  4. Salah HM, Mehta JL. Best time for administration of antihypertensive medications: morning or evening? Lancet. 2022 10 22; 400(10361):1383-1385.
    View in: PubMed
    Score: 0.175
  5. Sharma T, Mathur P, Mehta JL. Daytime or Nighttime Administration of Antihypertensive Medications? Am J Hypertens. 2020 11 03; 33(11):987-989.
    View in: PubMed
    Score: 0.153
  6. Saad M, Salehi N, Ding Z, Mehta JL. Blood pressure target in diabetics: how low is too low? Eur Heart J. 2019 07 01; 40(25):2044-2046.
    View in: PubMed
    Score: 0.139
  7. Zhang LL, Zhang Y, Cheng YQ, Zhang JM, Liu HQ, Wang WZ, Mehta JL, Xiong ZG, Su DF, Liu AJ. Metabolic syndrome emerges after artificial selection for low baroreflex sensitivity. CNS Neurosci Ther. 2018 09; 24(9):828-836.
    View in: PubMed
    Score: 0.130
  8. Ding Z, Liu S, Wang X, Khaidakov M, Fan Y, Deng X, Xiang D, Mehta JL. Lectin-like oxidized low-density lipoprotein receptor-1 regulates autophagy and Toll-like receptor 4 in the brain of hypertensive mice. J Hypertens. 2015 Mar; 33(3):525-33; discussion 533.
    View in: PubMed
    Score: 0.103
  9. Wang X, Khaidakov M, Guo Z, Ding Z, He Q, Mehta JL. LOX-1 deletion limits cardiac angiogenesis in mice given angiotensin II. Cardiovasc Drugs Ther. 2014 Oct; 28(5):441-6.
    View in: PubMed
    Score: 0.100
  10. Badheka AO, Patel NJ, Grover PM, Shah N, Patel N, Singh V, Deshmukh AJ, Mehta K, Chothani A, Savani GT, Arora S, Rathod A, Marzouka GR, Lafferty J, Mehta JL, Mitrani RD. Optimal blood pressure in patients with atrial fibrillation (from the AFFIRM Trial). Am J Cardiol. 2014 Sep 01; 114(5):727-36.
    View in: PubMed
    Score: 0.098
  11. Lu J, Wang X, Wang W, Muniyappa H, Deshmukh A, Hu C, Das K, Mehta JL. Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation. Kidney Int. 2012 Aug; 82(4):436-44.
    View in: PubMed
    Score: 0.086
  12. Kang BY, Hu C, Ryu S, Khan JA, Biancolella M, Prayaga S, Seung KB, Novelli G, Mehta P, Mehta JL. Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice. Physiol Genomics. 2010 Jun; 42(1):42-54.
    View in: PubMed
    Score: 0.073
  13. Kang BY, Wang W, Palade P, Sharma SG, Mehta JL. Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine. J Cardiovasc Pharmacol. 2009 Oct; 54(4):327-34.
    View in: PubMed
    Score: 0.071
  14. Hu C, Kang BY, Megyesi J, Kaushal GP, Safirstein RL, Mehta JL. Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int. 2009 Sep; 76(5):521-7.
    View in: PubMed
    Score: 0.070
  15. Hu C, Dandapat A, Sun L, Marwali MR, Inoue N, Sugawara F, Inoue K, Kawase Y, Jishage K, Suzuki H, Hermonat PL, Sawamura T, Mehta JL. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension. 2008 Sep; 52(3):556-62.
    View in: PubMed
    Score: 0.065
  16. Gardner SF, Franks AM, Gurley BJ, Haller CA, Singh BK, Mehta JL. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers. Am J Cardiol. 2003 Jun 15; 91(12):1510-3, A9.
    View in: PubMed
    Score: 0.046
  17. Chen H, Li D, Saldeen T, Mehta JL. TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol. 2003 May; 284(5):H1612-7.
    View in: PubMed
    Score: 0.045
  18. Powers SK, Lennon SL, Quindry J, Mehta JL. Exercise and cardioprotection. Curr Opin Cardiol. 2002 Sep; 17(5):495-502.
    View in: PubMed
    Score: 0.043
  19. Liu AJ, Guo JM, Liu W, Su FY, Zhai QW, Mehta JL, Wang WZ, Su DF. Involvement of arterial baroreflex in the protective effect of dietary restriction against stroke. J Cereb Blood Flow Metab. 2013 Jun; 33(6):906-13.
    View in: PubMed
    Score: 0.022
  20. Han P, Shen FM, Xie HH, Chen YY, Miao CY, Mehta JL, Sassard J, Su DF. The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats. J Cell Mol Med. 2009 Apr; 13(4):726-34.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.